Signs

SUNNYVALE, California - Radiofrequency ablation is durable after 2 years, compares favorably with endoscopic resection for advanced disease, and reduces the risk for cancer progression Results from a number of clinical trials were presented during the Digestive Disease Week (DDW) in Chicago this week, revealing new outcomes data related to endoscopic radiofrequency ablation using the HALO ablation system for eradicating a pre-cancerous esophageal condition known as Barrett's esophagus.

LONDON and CHICAGO - The Next Generation: the re-emergence of traditional ideologies A shift in Islamist terrorist activity from the Middle East to South Asia is the primary feature of the Aon 2009 Terrorism Threat Map, launched today by Aon Crisis Management.

SUNNYVALE, California - Large multi-center trial conducted in a community practice setting demonstrates comparable outcomes as trials conducted in predominantly tertiary academic centers Clinical trial results presented at the Digestive Disease Week in Chicago today reveal that endoscopic radiofrequency ablation performed in a community practice setting is safe and effective for eradicating a pre-cancerous esophageal condition known as Barrett's esophagus.

LONDON - YouGov Survey Reveals Low Awareness of Potentially Fatal Heart Condition That Affects Significant Number of People in UK LONDON, May 27 /PRNewswire/ -- As many as 700,000 people in the UK suffer from a heart abnormality called arrhythmia, a potentially fatal condition, which the majority of Londoners have never heard of - according to a recent survey conducted by YouGov[1].

PRAGUE - Ointment (Tacrolimus Monohydrate) in a New Twice-Weekly Regimen can Help Prevent Eczema Flares Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals.